FDA approves nivolumab/cabozantinib combo for frontline kidney cancer
January 22, 2021
The approval is based on data from the phase 3 CheckMate-9ER trial.
January 22, 2021
Recent legislation appears to have delayed implementation of the new code.
January 22, 2021
The approval is based on data from the phase 3 CheckMate-9ER trial.
January 22, 2021
"Everything comes down to patient selection and location of the stones," says one urologist.